Depressive symptoms predict clinical recurrence of inflammatory bowel disease
Open accessPublished version of a preprint
The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index; 3 of the 28 sources its claims cite were checked for support.
Abstract
BACKGROUND: Inflammatory bowel disease (IBD) patients are at high risk for depression, and depression has been shown to affect disease course. We examined interrelations between depression, genetic risk factors for depression, and IBD flares. METHOD: In 1973 patients (1137 Crohn's disease, 836 ulcerative colitis) of the Swiss IBD Cohort Study (SIBDCS), depressive status (hospital anxiety and depression subscale for depression, HADS-D ≥11) was assessed on a yearly basis. We investigated the impact of depression on IBD-relevant clinical outcomes in Cox proportional hazards models. We used active disease (CDAI ≥150 or MTWAI ≥10) and 2 published composite flare definitions-FNCE (physician-reported flare, nonresponse to therapy, new complication, or extraintestinal manifestation) and AFFSST (active disease, physician-reported flare, fistula, stenosis, and new systemic therapy)-as clinical end points. Additionally, 62 preselected single nucleotide polymorphisms (SNPs) were screened for cross-sectional associations with depression, and if present, their predictive value for future depression and clinical deterioration was assessed. RESULTS: Depression was a strong risk factor for disease-related end points, including active disease (adjusted hazard ratio [aHR], 3.55; P < 0.001), AFFSST (aHR, 1.62; P < 0.001), and FNCE (aHR, 1.35; P = 0.019). The SNP rs2522833 was significantly associated with depression at enrollment (q = 0.059). The TC allele of rs588765 was negatively associated with the presence of depression at enrollment (q = 0.050) and after enrollment (aHR, 0.67; P = 0.035) and with fewer active disease states (aHR, 0.72; P = 0.045) during follow-up. CONCLUSION: In IBD, depressive symptoms and inflammatory activity are intimately related. Depressive symptoms were a strong predictor of clinical deterioration, and genetic markers may play a role in this relationship.
Overview
CoChat Summary
TL;DR
In this Swiss IBD cohort study, depressive symptoms at a visit predicted later clinical worsening of IBD, including active disease and composite flare outcomes. The study also found that rs588765-TC was associated with less depression and less IBD activity over time, while rs2522833’s C allele was associated with depressive symptoms at baseline.
Key findings
- In 1973 genotyped SIBDC patients (1137 Crohn’s disease, 836 ulcerative colitis/IC), depressive symptoms at follow-up were associated with later active disease: adjusted hazard ratio (aHR) 3.25, p<0.001.
- Depressive symptoms also predicted the composite flare endpoints: AFFSST (aHR 1.62, p<0.001) and FNCE (aHR 1.35, p=0.019).
- Of 62 SNPs tested after linkage-disequilibrium pruning from 95 to 62, two SNPs were associated with depressive symptoms at baseline (q<0.1): rs588765-TC was protective (OR 0.43, q=0.050 after variable elimination) and rs2522833’s C allele increased odds of depression (OR 1.73, q=0.059).
- In time-to-event analyses, rs588765-TC remained protective for new or persistent depressive symptoms (aHR 0.67, p=0.035) and was also associated with fewer active disease states during follow-up (aHR 0.72, p=0.045); rs2522833 was not significantly associated with outcomes over time.
Methods
- Prospective cohort analysis within the Swiss IBD cohort study, which recruits nationwide in Switzerland and follows patients yearly; only genotyped patients with available biomaterial were included.
- Baseline and follow-up data were available for 1973 genotyped patients; depressive symptoms were defined as HADS-D ≥ 11, and disease activity used CDAI ≥ 150 for Crohn’s disease or MTWAI ≥ 10 for ulcerative colitis/IC.
- The authors screened 62 SNPs for association with depression using logistic regression, then tested depression and SNP effects on time-to-event outcomes with Cox proportional hazards models, including multivariable adjustment.
Limitations
- The paper states that the genetic analyses had a relatively small sample size, which reduced statistical power.
- The paper states that missing data points, such as therapy or surgery data, further reduced statistical power.
- The paper states that HADS-D ≥ 11 indicates probable depression, but a true depression diagnosis normally requires direct clinical assessment by a psychiatrist.
- Evident from the text: this is an observational cohort study, so the reported associations cannot by themselves establish causality.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
3 Valid · 0 Not valid · 13 Not checked · 67 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“Inflammatory bowel disease (IBD) patients are at high risk for depression.”
- Also stated in: § Introduction · plain
“the risk to experience depression is higher for IBD patients compared to healthy individuals (incidence rate ratio: 1.6). 6”
What the sources say
- Supportedcites [6] Sun, 2019, Stress triggers flare of inflammatory bowel disease in children and adults, Front Pediatr. source
The review's section 'Prevalence of Psychological Comorbidities in IBD' (Psychological Comorbidities in Adult IBD, p. ~4) states that in an IBD cohort patients exhibited a high incidence of psychological distress and comorbidities including depression, that IBD patients showed a three-fold higher incidence of depression than healthy people, and that IBD acted as an independent risk factor for depression in NHANES. The Neuendorf systematic review cited there reports 22% of IBD patients develop depression symptoms and 15% a depressive disorder, and the section concludes 'Overall, IBD patients are more prone to developing emotional disorders than the general population.' The childhood subsection likewise reports higher prevalence of anxiety/depression in adolescents with IBD, so the claim holds for the pediatric and adult populations the review covers. As a review, it reports these figures from the primary studies it cites, which supports the attributed claim. (LLM, conf=0.92)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Introduction · plain
Every source the paper cites for this claim was checked and supports it.
In the paper
“active disease further increases the hazard for depression. 6”
What the sources say
- Supportedcites [6] Sun, 2019, Stress triggers flare of inflammatory bowel disease in children and adults, Front Pediatr. source
In “Prevalence of Psychological Comorbidities in IBD” (page unavailable), the review reports that depression symptoms and depressive disorder occur in patients with IBD and that psychological comorbidity is more prevalent during active disease. This supports the claim that active disease is associated with greater risk of depression, although the passage does not give a depression-specific hazard ratio. (LLM, conf=0.86)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“overdominance model (TC vs. TT or CC) seemed to provide the best fit for Cox 423”
- Also stated in: § Genetic inheritance patterns of rs588765 and rs2522833 420 · plain
“proportional models with depressive symptoms over time and active disease as 424”
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Genetic inheritance patterns of rs588765 and rs2522833 420 · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Patients with depressive symptoms (HADS-D ≥ 11) had a significantly higher hazard of experiencing active disease (CDAI ≥ 150/MTWAI ≥ 10) during follow-up (HR: 3.18, p<0.001, Table 5 and Supplementary figure 6; panel A ); this association remained significant after correction for confounders (aHR: 3.25, p<0.001, Table 5 and Figure 2; panel A ).”
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“new uveitis/iritis (aHR: 2.01, p=0.046) in multivariable models were observed”
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
40 more claims
Create a free account to see all 83 claims and to verify the 25 references still open.
- Probably not a substantial claim. 29
- It may state two separate claims as one. 11
- The quote only partly states this claim. 3
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In addition, elevated depressive symptoms were associated with the onset of new extraintestinal manifestations, including peripheral arthritis/arthralgia (aHR: 1.42; 95% CI: 1.02, 1.98), primary sclerosing cholangitis (aHR: 3.97; 95% CI: 1.35, 11.68), and uveitis/iritis (aHR: 2.24; 95% CI: 1.17, 4.29) (20).”
From The 2023 Impact of Inflammatory Bowel Disease in Canada: Mental Health and Inflammatory Bowel Disease (2023) · cites this paper as [20]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The Swiss IBD Cohort Study (n = 1,973), which evaluated depression annually, found that elevated depressive symptoms were strong risk factors for multiple adverse disease outcomes, including recurrence of active disease (adjusted hazard ratio [aHR]: 3.55; 95% CI: 2.34, 5.39), a new fistula (aHR: 1.81; 95% CI: 1.03, 3.17), having surgery (aHR: 2.16; 95% CI: 1.48, 3.17)”
From The 2023 Impact of Inflammatory Bowel Disease in Canada: Mental Health and Inflammatory Bowel Disease (2023) · cites this paper as [20]
Experimental — accuracy not yet measured
Citations
Cites
R: A Language and Environment for Statistical Computing
R Core Team (2025) · doi:10.32614/r.manuals · Cited by 352,181
The Hospital Anxiety and Depression Scale
Zigmond, A. S., & Snaith, R. P. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb09716.x · Cited by 47,139
The validity of the Hospital Anxiety and Depression Scale
Bjelland, I., Dahl, A. A., Haug, T. T., & Neckelmann, D. (2002) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(01)00296-3 · Cited by 9,779
Genetic Epidemiology of Major Depression: Review and Meta-Analysis
Sullivan, P. F., Neale, M. C., & Kendler, K. S. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.10.1552 · Cited by 3,431
Herrmann, C. (1997) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(96)00216-4 · Cited by 2,885
Howard, D. M., Adams, M. J., Clarke, T.-K., Hafferty, J. D., Gibson, J., Shirali, M., Coleman, J. R. I., Hagenaars, S. P., Ward, J., Wigmore, E. M., et al. (2019) · Nature Neuroscience · doi:10.1038/s41593-018-0326-7 · Cited by 2,565
The Hospital Anxiety And Depression Scale.
(2003) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-1-29 · Cited by 2,391
Cyclosporine in Severe Ulcerative Colitis Refractory to Steroid Therapy
Lichtiger, S., Present, D. H., Kornbluth, A., Gelernt, I., Bauer, J., Galler, G., Michelassi, F., & Hanauer, S. (1994) · New England Journal of Medicine · doi:10.1056/nejm199406303302601 · Cited by 1,714
Carlson, C. S., Eberle, M. A., Rieder, M. J., Yi, Q., Kruglyak, L., & Nickerson, D. A. (2004) · The American Journal of Human Genetics · doi:10.1086/381000 · Cited by 1,589
Inflammatory bowel disease: Pathogenesis
Zhang, Y.-Z. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i1.91 · Cited by 1,507
Research works printed but not linked: 4
- National Cancer Institute (NCI), ., NCI’s Dictionary of Genetics Terms.
- Therneau, 2020, A Package for Survival Analysis in R
- Baer, 2013, Depressionen in der Schweizer Bevölkerung: Daten zur Epidemiologie, Behandlung und sozial-beruflichen Integration
- Kessler, 2009, Epidemiology of depression, 5
Cited by
Fairbrass, K. M., Lovatt, J., Barberio, B., Yuan, Y., Gracie, D. J., & Ford, A. C. (2022) · Gut · doi:10.1136/gutjnl-2021-325985 · Cited by 225
Ge, L., Liu, S., Li, S., Yang, J., Hu, G., Xu, C., & Song, W. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1016578 · Cited by 187
“The course of IBD is long and variable, often alternating between periods of quiescent disease and periods of relapsing disease with more active inflammatory episodes (7).”
BackgroundFairbrass, K. M., Gracie, D. J., & Ford, A. C. (2022) · Gastroenterology · doi:10.1053/j.gastro.2022.03.014 · Cited by 66
Massironi, S., Pigoni, A., Vegni, E. A. M., Keefer, L., Dubinsky, M. C., Brambilla, P., Delvecchio, G., & Danese, S. (2024) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izae206 · Cited by 62
Wang, C., Gu, Y., Chu, Q., Wang, X., Ding, Y., Qin, X., Liu, T., Wang, S., Liu, X., Wang, B., et al. (2024) · Microbiological Research · doi:10.1016/j.micres.2024.127660 · Cited by 58
Metadata
- Authors
- Jordi, S. B. U., Lang, B. M., Auschra, B., von Känel, R., Biedermann, L., Greuter, T., Schreiner, P., Rogler, G., Krupka, N., Sulz, M. C., Misselwitz, B., Begré, S., Swiss IBD Cohort Study Group, Anderegg, C., Bauerfeind, P., Beglinger, C., Begré, S., Belli, D., Bengoa, J. M., Biedermann, L., Bigler, B., Binek, J., Blattmann, M., Boehm, S., Borovicka, J., Braegger, C. P., Brunner, N., Bühr, P., Burnand, B., Burri, E., Buyse, S., Cremer, M., Criblez, D. H., de Saussure, P., Degen, L., Delarive, J., Doerig, C., Dora, B., Dorta, G., Egger, M., Ehmann, T., El-Wafa, A., Engelmann, M., Ezri, J., Felley, C., Fliegner, M., Fournier, N., Fraga, M., Frei, P., Frei, R., Fried, M., Froehlich, F., Funk, C., Furlano, R. I., Gallot-Lavallée, S., Geyer, M., Girardin, M., Golay, D., Grandinetti, T., Gysi, B., Haack, H., Haarer, J., Helbling, B., Hengstler, P., Herzog, D., Hess, C., Heyland, K., Hinterleitner, T., Hiroz, P., Hirschi, C., Hruz, P., Iwata, R., Jost, R., Juillerat, P., Brondolo, V. K., Knellwolf, C., Knoblauch, C., Köhler, H., Koller, R., Krieger-Grübel, C., Kullak-Ublick, G., Künzler, P., Landolt, M., Lange, R., Lehmann, F. S., Macpherson, A., Maerten, P., Maillard, M. H., Manser, C., Manz, M., Marbet, U., Marx, G., Matter, C., McLin, V., Meier, R., Mendanova, M., Meyenberger, C., Michetti, P., Misselwitz, B., Moradpour, D., Morell, B., Mosler, P., Mottet, C., Müller, C., Müller, P., Müllhaupt, B., Münger-Beyeler, C., Musso, L., Nagy, A., Neagu, M., Nichita, C., Niess, J., Noël, N., Nydegger, A., Obialo, N., Oneta, C., Oropesa, C., Peter, U., Peternac, D., Petit, L. M., Piccoli-Gfeller, F., Pilz, J. B., Pittet, V., Raschle, N., Rentsch, R., Restellini, S., Richterich, J.-P., Rihs, S., Ritz, M. A., Roduit, J., Rogler, D., Rogler, G., Rossel, J.-B., Sagmeister, M., Saner, G., Sauter, B., Sawatzki, M., Schäppi, M., Scharl, M., Schelling, M., Schibli, S., Schlauri, H., Uebelhart, S. S., Schnegg, J.-F., Schoepfer, A., Seibold, F., Seirafi, M., Semadeni, G.-M., Semela, D., Senning, A., Sidler, M., Sokollik, C., Spalinger, J., Spangenberger, H., Stadler, P., Steuerwald, M., Straumann, A., Straumann-Funk, B., Sulz, M., Thorens, J., Tiedemann, S., Tutuian, R., Vavricka, S., Viani, F., Vögtlin, J., von Känel, R., Vonlaufen, A., Vouillamoz, D., Vulliamy, R., Wermuth, J., Werner, H., Wiesel, P., Wiest, R., Wylie, T., Zeitz, J., & Zimmermann, D.
- Affiliations
- University of Bern (CH)
- University Hospital of Basel (CH)
- University of Zurich (CH)
- Department of Gastroenterology and Hepatology, Kantonsspital St. Gallen , St. Gallen , Switzerland
- Kantonsspital St. Gallen (CH)
- ORCID
- Jordi, Sebastian Bruno Ulrich
- Lang, Brian Matthew
- Auschra, Bianca
- Greuter, Thomas
- Schreiner, Philipp
- Krupka, Niklas
- Beglinger, Christoph
- Braegger, Christian P
- Burnand, Bernard
- Burri, Emanuel
- Degen, Lukas
- Fournier, Nicolas
- Fraga, Montserrat
- Froehlich, Florian
- Geyer, Martin
- Herzog, Denise
- Hruz, Petr
- Juillerat, Pascal
- Knoblauch, Christoph
- Köhler, Henrik
- Kullak-Ublick, Gerd
- Landolt, Markus
- Lehmann, Frank Serge
- Macpherson, Andrew
- McLin, Valérie
- Michetti, Pierre
- Moradpour, Darius
- Morell, Bernhard
- Müller, Pascal
- Müllhaupt, Beat
- Nichita, Cristina
- Niess, Jan
- Nydegger, Andreas
- Restellini, Sophie
- Rossel, Jean-Benoît
- Sawatzki, Mikael
- Scharl, Michael
- Schoepfer, Alain
- Seibold, Frank
- Semela, David
- Sokollik, Christiane
- Spalinger, Johannes
- Straumann, Alex
- Tutuian, Radu
- Vavricka, Stephan
- Vonlaufen, Alain
- Werner, Helene
- Wiest, Reiner
- Zeitz, Jonas
- Venue
- Inflammatory Bowel Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2021-06-07
- Volume
- 28
- Issue
- 4
- Pages
- 560-571
- ISSN
- 1078-0998 (ISSN-L)
- 1536-4844
- OpenAlex
- W3166723635
- Semantic Scholar
- f82d22931f033049b34b438d7c164518b3492b35
- Cited by
- 41
- References
- 72
- Citations by year
- 2026: 4 · 2025: 11 · 2024: 6 · 2023: 8 · 2022: 10 · 2021: 2
- FWCI
- 3.67
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Licence
- Locations
- Inflammatory Bowel Diseases (publishedVersion)
- medRxiv (acceptedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- BORIS (University Library Bern) (submittedVersion)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion)
- Funders
- Swiss National Science Foundation (33CS30-148422)
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Keywords
- inflammatory bowel disease, depression
- MeSH terms
- Cross-Sectional Studies, Depression, Humans, Recurrence, Inflammatory Bowel Diseases, Cohort Studies, Polymorphism, Single Nucleotide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Depressive symptoms predict clinical recurrence of inflammatory bowel disease. https://app.cochat.ai/papers/10.1093/ibd/izab136
- The paper
- Jordi, S. B. U., Lang, B. M., Auschra, B., von Känel, R., Biedermann, L., Greuter, T., Schreiner, P., Rogler, G., Krupka, N., Sulz, M. C., Misselwitz, B., Begré, S., Swiss IBD Cohort Study Group, Anderegg, C., Bauerfeind, P., Beglinger, C., Begré, S., Belli, D., Bengoa, J. M., . . . Zimmermann, D. (2022). Depressive symptoms predict clinical recurrence of inflammatory bowel disease. Inflammatory Bowel Diseases. https://doi.org/10.1093/ibd/izab136
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.